MergerLinks Header Logo

Announced

Laboratorios Sanfer to acquire Vitalis from ACON Investments.

Synopsis

Laboratorios Sanfer, a pharmaceutical company, agreed to acquire Vitalis, a manufacturer and wholesaler of injectable products used in hospitals, medical institutions and pharmacies, from ACON Investments, a private equity firm. Financial terms were not disclosed. "The team at Vitalis is enthusiastic to begin this new era of growth, consolidating its position as a key player in the Latin American pharmaceutical market. We are confident that Sanfer's experience, know-how and leadership will exponentially boost the company's growth and expansion plans," Alberto Hernandez, ACON Partner.

Principals

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Sort

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US